Armstrong Advisory Group Inc. Purchases 174 Shares of Colgate-Palmolive (NYSE:CL)

Armstrong Advisory Group Inc. raised its holdings in Colgate-Palmolive (NYSE:CL) by 2.4% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 7,326 shares of the company’s stock after buying an additional 174 shares during the quarter. Armstrong Advisory Group Inc.’s holdings in Colgate-Palmolive were worth $760,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. bought a new stake in shares of Colgate-Palmolive in the 2nd quarter worth about $25,000. Rise Advisors LLC acquired a new position in shares of Colgate-Palmolive in the 1st quarter worth approximately $38,000. Continuum Advisory LLC increased its holdings in Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after purchasing an additional 125 shares in the last quarter. Register Financial Advisors LLC bought a new position in Colgate-Palmolive in the 1st quarter valued at $48,000. Finally, Gradient Investments LLC boosted its stake in Colgate-Palmolive by 150.4% in the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after purchasing an additional 400 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Insider Activity

In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now owns 13,942 shares in the company, valued at approximately $1,439,929.76. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Colgate-Palmolive news, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total value of $1,085,952.30. Following the transaction, the executive vice president now directly owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 43,490 shares of company stock valued at $4,486,063 over the last quarter. 0.34% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on CL shares. Wells Fargo & Company cut shares of Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 price objective for the company. in a research report on Monday, September 16th. HSBC reissued a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Citigroup increased their price objective on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Barclays boosted their price objective on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Finally, Bank of America boosted their price target on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $106.00.

Colgate-Palmolive Stock Up 0.9 %

CL stock opened at $100.10 on Monday. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. Colgate-Palmolive has a 52 week low of $68.54 and a 52 week high of $109.30. The company has a market cap of $82.13 billion, a PE ratio of 31.68, a price-to-earnings-growth ratio of 3.54 and a beta of 0.40. The business has a 50-day simple moving average of $103.56 and a 200 day simple moving average of $97.25.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. The firm had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business’s revenue for the quarter was up 4.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.77 earnings per share. Sell-side analysts anticipate that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is 63.29%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.